Viewing StudyNCT00145145



Ignite Creation Date: 2024-05-05 @ 11:49 AM
Last Modification Date: 2024-10-26 @ 9:14 AM
Study NCT ID: NCT00145145
Status: TERMINATED
Last Update Posted: 2022-10-07
First Post: 2005-09-01

Brief Title: Immunization With the MAGE-3A1 Peptide Mixed With the Adjuvant CpG 7909 in Patients With Metastatic Melanoma
Sponsor: Ludwig Institute for Cancer Research
Organization: Ludwig Institute for Cancer Research

Conditions & Keywords Data

Conditions:
Name
Malignant Melanoma
Keywords:
Name View
CpG View
Melanoma View
Vaccine View
Peptide View
MAGE View